Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study
Abroad (travel likely)RecruitingPHASE2
Conditions
Asthma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Jewish Health, Denver, Colorado, United States
Study leads
Michael Wechsler, MD
Principal Investigator
National Jewish Health